Geode Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.7M Buy
1,295,485
+116,268
+10% +$1.68M ﹤0.01% 1998
2025
Q1
$8.14M Buy
1,179,217
+24,439
+2% +$169K ﹤0.01% 2417
2024
Q4
$6.13M Buy
1,154,778
+5,186
+0.5% +$27.5K ﹤0.01% 2645
2024
Q3
$4.2M Buy
1,149,592
+17,963
+2% +$65.6K ﹤0.01% 2850
2024
Q2
$3.09M Buy
1,131,629
+570,570
+102% +$1.56M ﹤0.01% 2969
2024
Q1
$1.95M Buy
561,059
+57,116
+11% +$199K ﹤0.01% 3118
2023
Q4
$721K Hold
503,943
﹤0.01% 3469
2023
Q3
$736K Sell
503,943
-20,456
-4% -$29.9K ﹤0.01% 3448
2023
Q2
$823K Sell
524,399
-33,036
-6% -$51.9K ﹤0.01% 3430
2023
Q1
$853K Sell
557,435
-1,414
-0.3% -$2.16K ﹤0.01% 3414
2022
Q4
$938K Buy
558,849
+5,524
+1% +$9.27K ﹤0.01% 3374
2022
Q3
$680K Buy
553,325
+4,588
+0.8% +$5.64K ﹤0.01% 3574
2022
Q2
$916K Sell
548,737
-375,326
-41% -$627K ﹤0.01% 3467
2022
Q1
$2.27M Buy
924,063
+42,795
+5% +$105K ﹤0.01% 3199
2021
Q4
$3.3M Buy
881,268
+17,054
+2% +$63.8K ﹤0.01% 3123
2021
Q3
$5.42M Buy
864,214
+43,482
+5% +$273K ﹤0.01% 2866
2021
Q2
$8.09M Buy
820,732
+84,995
+12% +$838K ﹤0.01% 2612
2021
Q1
$6.87M Buy
735,737
+79,312
+12% +$741K ﹤0.01% 2620
2020
Q4
$3.15M Buy
656,425
+26,589
+4% +$128K ﹤0.01% 2842
2020
Q3
$2.53M Buy
629,836
+16,854
+3% +$67.6K ﹤0.01% 2754
2020
Q2
$2.81M Buy
612,982
+25,350
+4% +$116K ﹤0.01% 2659
2020
Q1
$1.92M Buy
587,632
+88,699
+18% +$289K ﹤0.01% 2692
2019
Q4
$2.15M Buy
498,933
+65,762
+15% +$283K ﹤0.01% 2957
2019
Q3
$1.7M Buy
433,171
+15,216
+4% +$59.9K ﹤0.01% 3024
2019
Q2
$1.94M Buy
417,955
+38,320
+10% +$178K ﹤0.01% 2975
2019
Q1
$1.59M Buy
379,635
+32,912
+9% +$138K ﹤0.01% 2980
2018
Q4
$1.19M Buy
346,723
+17,361
+5% +$59.5K ﹤0.01% 3033
2018
Q3
$1.41M Buy
329,362
+34,123
+12% +$146K ﹤0.01% 3073
2018
Q2
$1.1M Buy
295,239
+119,802
+68% +$444K ﹤0.01% 3149
2018
Q1
$736K Hold
175,437
﹤0.01% 3263
2017
Q4
$1.03M Hold
175,437
﹤0.01% 3083
2017
Q3
$754K Buy
175,437
+8,738
+5% +$37.6K ﹤0.01% 3219
2017
Q2
$636K Sell
166,699
-27,605
-14% -$105K ﹤0.01% 3274
2017
Q1
$522K Buy
194,304
+6,506
+3% +$17.5K ﹤0.01% 3300
2016
Q4
$621K Buy
187,798
+12,395
+7% +$41K ﹤0.01% 3193
2016
Q3
$522K Buy
175,403
+3,033
+2% +$9.03K ﹤0.01% 3229
2016
Q2
$713K Buy
+172,370
New +$713K ﹤0.01% 3060